Evidence map›Paper›PMID 38628314›Full record

ArticleFrontiers in cardiovascular medicine2024

MicroRNA analysis of medium/large placenta extracellular vesicles in normal and preeclampsia pregnancies.

Toluwalase Awoyemi, Shuhan Jiang, Maryam Rahbar, Prasanna Logentherian, Gavin Collett, Wei Zhang, Adam Cribbs, Sofia Cerdeira, Manu Vatish

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Endothelial Dysfunction in Preeclampsia: Focus on the Uteroplacental Circulation.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  4. Article
  5. Clinical Applications of Extracellular Vesicles: Promises and Pitfalls.International journal of molecular sciences · 2026
    Review
  6. Review
  7. Crosstalk of extracellular vesicles in maternal-fetal interaction.Frontiers in cell and developmental biology · 2026
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Toluwalase AwoyemiNuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.
Shuhan JiangNuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.
Maryam RahbarNuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.
Prasanna LogentherianNuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.
Gavin CollettNuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.
Wei ZhangNuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.
Adam CribbsNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.
Sofia CerdeiraNuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.
Manu VatishNuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.
University of Oxford · GBNuffield Orthopaedic Centre · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Preeclampsia (PE) is a hypertensive disorder of pregnancy, affecting 2%-8% of pregnancies worldwide, and is the leading cause of adverse maternal and fetal outcomes. The disease is characterized by oxidative and cellular stress and widespread endothelial dysfunction. While the precise mechanisms are not entirely understood, the pathogenesis of PE is closely linked to placental dysfunction and, to some extent, syncytiotrophoblast extracellular vesicle release (STB-EVs). These vesicles can be divided into the less well-studied medium/large EVs (220-1,000 nm) released in response to stress and small EVs (<220 nm) released as a component of intercellular communication. The previously described production of m/lSTB-EVs in response to cellular stress combined with the overwhelming occurrence of cellular and oxidative stress in PE prompted us to evaluate the microRNAome of PE m/lSTB-EVs. We hypothesized that the microRNAome profile of m/lSTB-EVs is different in PE compared to normal pregnancy (NP), which might permit the identification of potential circulating biomarkers not previously described in PE. Methods/study design: We performed small RNA sequencing on medium/large STB-EVs isolated from PE and NP placentae using dual-lobe ex vivo perfusion. The sequencing data was bioinformatically analyzed to identify differentially regulated microRNAs. Identified microRNAs were validated with quantitative PCR analysis. We completed our analysis by performing an in-silico prediction of STB-EV mechanistic pathways. Results: We identified significant differences between PE and NP in the STB-EVs micro ribonucleic acid (microRNA) profiles. We verified the differential expression of Conclusions: We identified a differentially regulated micro-RNA,

Indexed as

biomarkersmechanismsmicroRNAplacenta EVspreeclampsiasyncytiotrophoblast membrane extracellular vesicles (STB-EVs)

Identifiers

PMID38628314
PMCPMC11018924
OpenAlexW4393442706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.